pet care
Unveil Elanco Q1 Dip, Pet Health vs Zoetis Surge
Elanco’s Q1 earnings showed a 4% dip in core EPS, indicating a short-term setback while its long-haul strategy is set to outpace peers. The company is banking on innovative canine supplements and a digital diagnostics push to reshape pet health profitability. Medical Disclaimer: This article is for informational purposes